ANI Pharmaceuticals ANIP Returned Goods Reserve
Returned Goods Reserve at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept anip:ReturnedGoodsReserve.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's returned goods reserve.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's returned goods reserve?
- ANI Pharmaceuticals (ANIP) reported returned goods reserve of $43.05M in Q1 2026.
- How has ANI Pharmaceuticals's returned goods reserve changed year-over-year?
- ANI Pharmaceuticals's returned goods reserve increased by 1.4% year-over-year, from $42.46M to $43.05M.
- What is the long-term trend for ANI Pharmaceuticals's returned goods reserve?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's returned goods reserve has grown at a 12.8% compound annual growth rate (CAGR), from $27.16M to $49.5M.
- What does returned goods reserve mean?
- This represents the estimated liability for products expected to be returned by customers, typically due to expiration, damage, or inventory management practices. It is a critical provision in the pharmaceutical industry to ensure revenue is recognized net of expected returns. A rising reserve may signal potential issues with product quality, overstocking in the distribution channel, or shifts in market demand.